Skip to main content
2022 Guide to Patient Support Services

ADC Therapeutics

2022 Oncology Guide to Patient Support Services

ADC Therapeutics Advancing Patient Support

855-690-0340

ADC Therapeutics offers the Advancing Patient Support program to assist patients and their healthcare providers access to Zynlonta (Table).

Advancing Patient Support

Advancing Patient Support’s dedicated case managers can serve as a single point of contact to help patients get started and stay on Zynlonta. Case managers can assist with coverage support such as benefits investigation, financial support through the Copay Assistance Program and the Patient Assistance Program, and nursing support to answer questions about treatment with Zynlonta.

Copay Assistance Program

Patients may be eligible for the Copay Assistance Program if they:

  • Are aged ≥18 years
  • Live and receive treatment in the United States or US territories
  • Have a valid prescription for Zynlonta for an FDA-approved indication
  • Have private or commercial health insurance with coverage for Zynlonta.

Patient Assistance Program

Advancing Patient Support’s Patient Assistance Program offers patients who are uninsured or underinsured Zynlonta for free if they meet certain criteria. To determine eligibility to enroll in the Patient Assistance Program, ADC Therapeutics and its representatives will assess the patient’s income and verify financial information with W-2 and tax return documentation.

Enroll your patient in the Advancing Patient Support program by either completing the form online or by downloading the form and submitting via fax at 855-915-3005 or e-mailing to This email address is being protected from spambots. You need JavaScript enabled to view it..

TABLE ADC Therapeutics Oncology Drug

Drug
Indications
Patient support programs

Drug
Zynlonta (loncastuximab tesirine-lpyl) for injection
Indications
Treatment of adult patients with relapsed or refractory large B-cell lymphoma after 2 or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, DLBCL arising from low-grade lymphoma, and high-grade B-cell lymphoma
Patient support program

Report Broken Links

Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?

Help us fix it! Report broken links here.

Report Broken Links

Report Broken Links

*OPM Webpage
Please copy the URL (link) of the OPM webpage you are currently on.
*Broken Link
Please copy the URL (link) to the external webpage that is not displaying content correctly.
Errors include, but are not limited to:
  • "This site can’t be reached"
  • "Hmm. We’re having trouble finding that site."
  • "Hmmm… can't reach this page"
  • "404 Error: Page not found"
Comments
(Optional)